Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease

  1. John P Grogan  Is a corresponding author
  2. Demitra Tsivos
  3. Laura Smith
  4. Brogan E Knight
  5. Rafal Bogacz
  6. Alan Whone
  7. Elizabeth J Coulthard  Is a corresponding author
  1. University of Bristol, United Kingdom
  2. North Bristol NHS Trust, United Kingdom
  3. University of Oxford, United Kingdom

Abstract

Emerging evidence suggests that dopamine may modulate learning and memory with important implications for understanding the neurobiology of memory and future therapeutic targeting. An influential hypothesis posits that dopamine biases reinforcement learning. More recent data also suggest an influence during both consolidation and retrieval. Eighteen Parkinson’s disease patients learned through feedback ON or OFF medication with memory tested 24 hours later ON or OFF medication (4 conditions, within-subjects design with matched healthy control group). Patients OFF medication during learning decreased in memory accuracy over the following 24 hours. In contrast to previous studies, however, dopaminergic medication during learning and testing did not affect expression of positive or negative reinforcement. Two further experiments were run without the 24-hour delay, but they too failed to reproduce effects of dopaminergic medication on reinforcement learning. While supportive of a dopaminergic role in consolidation, this study failed to replicate previous findings on reinforcement learning.

Article and author information

Author details

  1. John P Grogan

    Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    For correspondence
    john.grogan@bristol.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0463-8904
  2. Demitra Tsivos

    Clinical Neurosciences, North Bristol NHS Trust, Bristol, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Laura Smith

    Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Brogan E Knight

    Clinical Neurosciences, North Bristol NHS Trust, Bristol, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Rafal Bogacz

    Medical Research Council Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Alan Whone

    Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Elizabeth J Coulthard

    Institute of Clinical Neurosciences, School of Clinical Sciences, University of Bristol, Bristol, United Kingdom
    For correspondence
    elizabeth.coulthard@bristol.ac.uk
    Competing interests
    The authors declare that no competing interests exist.

Funding

Wellcome (PhD Studentshipt SJ1102)

  • John P Grogan

BRACE (Project grant)

  • John P Grogan
  • Elizabeth J Coulthard

Medical Research Council (MC UU 12024/5)

  • Rafal Bogacz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Joshua I Gold, University of Pennsylvania, United States

Ethics

Human subjects: Ethical approval was obtained from the NHS Research Ethics Committee at Frenchay, Bristol (09/H0107/18). All participants gave written consent, in accordance with the Declaration of Helsinki.

Version history

  1. Received: March 14, 2017
  2. Accepted: July 7, 2017
  3. Accepted Manuscript published: July 10, 2017 (version 1)
  4. Version of Record published: July 27, 2017 (version 2)

Copyright

© 2017, Grogan et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,504
    Page views
  • 423
    Downloads
  • 42
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. John P Grogan
  2. Demitra Tsivos
  3. Laura Smith
  4. Brogan E Knight
  5. Rafal Bogacz
  6. Alan Whone
  7. Elizabeth J Coulthard
(2017)
Effects of dopamine on reinforcement learning and consolidation in Parkinson’s disease
eLife 6:e26801.
https://doi.org/10.7554/eLife.26801

Share this article

https://doi.org/10.7554/eLife.26801

Further reading

    1. Neuroscience
    Sydney Trask, Nicole C Ferrara
    Insight

    Gradually reducing a source of fear during extinction treatments may weaken negative memories in the long term.

    1. Cell Biology
    2. Neuroscience
    Haibin Yu, Dandan Liu ... Kai Yuan
    Research Article

    O-GlcNAcylation is a dynamic post-translational modification that diversifies the proteome. Its dysregulation is associated with neurological disorders that impair cognitive function, and yet identification of phenotype-relevant candidate substrates in a brain-region specific manner remains unfeasible. By combining an O-GlcNAc binding activity derived from Clostridium perfringens OGA (CpOGA) with TurboID proximity labeling in Drosophila, we developed an O-GlcNAcylation profiling tool that translates O-GlcNAc modification into biotin conjugation for tissue-specific candidate substrates enrichment. We mapped the O-GlcNAc interactome in major brain regions of Drosophila and found that components of the translational machinery, particularly ribosomal subunits, were abundantly O-GlcNAcylated in the mushroom body of Drosophila brain. Hypo-O-GlcNAcylation induced by ectopic expression of active CpOGA in the mushroom body decreased local translational activity, leading to olfactory learning deficits that could be rescued by dMyc overexpression-induced increase of protein synthesis. Our study provides a useful tool for future dissection of tissue-specific functions of O-GlcNAcylation in Drosophila, and suggests a possibility that O-GlcNAcylation impacts cognitive function via regulating regional translational activity in the brain.